Mitralign, Inc. Shines At TCT 2006; Performs Live Case & Reveals Clinical Strategy
11/7/2006 3:03:45 PM
TEWKSBURY, Mass.--(BUSINESS WIRE)--For the first time, Mitralign demonstrated, in a pre-clinical model the capability of its Catheter-based Direct Annuloplasty System to treat mitral regurgitation (MR). This procedure that emulates surgical mitral valve repair was transmitted via satellite to the Trans-catheter Cardiovascular Therapeutics meeting in Washington DC last week. The session was moderated by course director, Dr. Martin Leon and included thought leading panel members Don Baim, MD and John Webb, MD.
comments powered by